• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of Personalized Medicine >Value-Based Pricing and Reimbursement in Personalised Healthcare: Introduction to the Basic Health Economics
【24h】

Value-Based Pricing and Reimbursement in Personalised Healthcare: Introduction to the Basic Health Economics

机译：个性化医疗保健中基于价值的定价和报销：基本卫生经济学简介

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

‘Value-based’ outcomes, pricing, and reimbursement are widely discussed as health sector reforms these days. In this paper, we discuss their meaning and relationship in the context of personalized healthcare, defined as receipt of care conditional on the results of a biomarker-based diagnostic test. We address the question: “What kinds of pricing and reimbursement models should be applied in personalized healthcare?” The simple answer is that competing innovators and technology adopters should have incentives that promote long-term dynamic efficiency. We argue that—to meet this social objective of optimal innovation in personalized healthcare—payers, as agents of their plan participants, should aim to send clear signals to their suppliers about what they value. We begin by revisiting the concept of value from an economic perspective, and argue that a broader concept of value is needed in the context of personalized healthcare. We discuss the market for personalized healthcare and the interplay between price and reimbursement. We close by emphasizing the potential barrier posed by inflexible or cost-based reimbursement systems, especially for biomarker-based predictive tests, and how these personalized technologies have global public goods characteristics that require global value-based differential pricing to achieve dynamic efficiency in terms of the optimal rate of innovation and adoption.
机译：如今，随着卫生部门的改革，“基于价值”的结果，定价和报销被广泛讨论。在本文中，我们讨论了个性化医疗保健中它们的含义和关系，个性化医疗保健的定义是接受基于生物标记物的诊断测试结果的护理。我们解决了一个问题：“个性化医疗应采用哪种定价和报销模式？”简单的答案是，竞争的创新者和技术采用者应具有促进长期动态效率的激励措施。我们认为，为了实现个性化医疗保健中实现最佳创新的社会目标，付款人作为其计划参与者的代理商，应旨在向其供应商发出明确的信号，告知他们他们所重视的东西。我们从经济角度重新审视价值概念，并提出在个性化医疗保健的背景下需要更广泛的价值概念。我们讨论个性化医疗保健市场以及价格与报销之间的相互作用。最后，我们着重强调灵活的或基于成本的报销系统（尤其是基于生物标志物的预测测试）构成的潜在障碍，以及这些个性化技术如何具有全球公益特性，这些特性要求全球基于价值的差异定价才能实现动态效率。创新和采用的最佳速率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号